Opens in a new tab

Edwards Lifesciences v Meril Italy (CFI, 30 April 2024)

Date30 April 2024
CourtCFI
DivisionParis (FR) Central Division - Seat
Type of actionGeneric application
Case number(s)UPC_CFI_255/2023
Registry referenceApp_19959/2024and23242/2024 · ORD_24620/2024 · UPC_CFI_255/2023
PartiesEdwards Lifesciences Corporation v. Meril Italy srl

Official decision (PDF) · UPC registry entry

Case timeline

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By an order of 30 April 2024 (UPC_CFI_255/2023, ACT_551308/2023, App_19959/2024 and App_23242/2024), the judge-rapporteur of panel 2 of the Paris Central Division (P. Catallozzi), in the revocation action brought by Meril Italy s.r.l. against EP 3 646 825, admitted the subsequent request to amend the patent lodged by Edwards Lifesciences Corporation after the written procedure had closed, and gave Meril one month to respond. The order accepts a late amendment where it narrows the dispute.

Question

May a subsequent request to amend the patent (Rule 30.2 RoP), lodged after the written procedure has closed, be admitted, and on what conditions?

Decision

A subsequent request requires the court’s permission, which is discretionary even after the time for the Defence has expired (paragraphs 7 and 8), since no time limit is set, it may come after the written procedure has closed provided the other party’s right of defence is not prejudiced (paragraph 9). The judge weighs efficiency and the narrowing of the dispute against delay and the other side’s rights, and the requesting party must justify the change (paragraphs 10 to 13). Alignment with the defence to the counterclaim is no justification (paragraph 17), reducing 84 auxiliary requests to one unconditional amendment and six auxiliary requests, however, improves efficiency and is fair (paragraphs 18 to 20). Lack of agreement between the parties is no bar (paragraphs 21 to 23). One month is given for an additional defence, without reopening the written procedure (paragraphs 24 and 25), Meril’s request for a rejoinder was refused, Edwards’ unauthorised reply being disregarded (paragraph 26).

Key points for practice

Provisions applied

Rules of Procedure
Rules 30, 50 and 263.1, and recitals 2 and 4 of the Preamble
European Patent Convention
Art. 84, 123(2) and (3)

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Decisions in the same proceedings

Going further

Lexicon: Written procedure (UPC), Court fees and costs (UPC).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_255/2023 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

  1. 13 November 2023 Edwards Lifesciences v Meril Italy (CFI, 13 November 2023) Preliminary objection · UPC_CFI_255/2023

    La division centrale reste compétente pour l'action en nullité de Meril Italy, filiale distincte des défenderesses à l'action en contrefaçon munichoise. La garantie pour les frais est refusée.

  2. 27 February 2024 Meril Italy v Edwards Lifesciences (CFI, UPC_CFI_255/2023, ORD_7184/2024, 27 February 2024) Generic application · UPC_CFI_255/2023
  3. 27 February 2024 Meril Italy v Edwards Lifesciences (CFI, UPC_CFI_255/2023, ORD_7184/2024, 27 February 2024, doc. 2) Generic application · UPC_CFI_255/2023
  4. 30 April 2024 Edwards Lifesciences v Meril Italy (CFI, 30 April 2024) Generic application · UPC_CFI_255/2023

What the record states

Nature of the act
Generic application
Outcome (Dhenne Avocats summary)
La demande ultérieure de modification du brevet est admise et Meril dispose d'un mois pour une défense complémentaire. La duplique est refusée.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 646 825
A system comprising a prosthetic valve and a delivery catheter
recorded proprietor: Edwards Lifesciences Corp
Mentioned in the analysis (role not qualified)
Also mentioned in 32 other decision(s): Edwards Lifesciences v Meril Life Sciences (CFI, 15 November 2024) · Meril Italy v Edwards Lifesciences (CFI, 19 July 2024) · Meril v Edwards Lifesciences (CFI, 19 July 2024) · Meril Italy v Edwards Lifesciences (CoA, 25 November 2025) · Edwards Lifesciences v Sintec (CFI, 5 September 2025) · Meril Italy v SWAT Medical (CoA, 5 May 2025) · Meril v SWAT Medical (CoA, 5 May 2025) · Meril Life Sciences v SWAT Medical (CoA, 5 May 2025)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.